SomaLogic

SomaLogic is a commercial-stage proteomics company founded in 2000, specializing in robust, high-throughput proteomics analysis. Its proprietary platform offers broad proteome coverage, low limits of detection, high reproducibility, and cost-effectiveness, enabling advancements in precision health and biomarker discovery. The company's technology is crucial for understanding complex biological systems and driving data-driven biomedical research and clinical diagnostics. With a focus on innovation, SomaLogic provides essential tools for life science research and healthcare improvement.

Operating with a workforce of 500 - 1,000 employees across 3 locations, SomaLogic is positioned to support a wide range of scientific endeavors. The company's scale and operational capacity enable it to serve diverse clients in the biotechnology and healthcare sectors. Understanding the human capital behind such advanced technology is key to its success, and details about their leadership and personnel can be explored by Meet SomaLogic's team. This team is instrumental in developing and deploying their cutting-edge measurement technology.

Financially, SomaLogic reported a revenue of $88.1M. The company has a history of significant funding rounds, indicating strong investor confidence in its technology and market potential. These financial resources fuel its ongoing research and development, expanding its capabilities in protein measurement and biomarker identification. For a deeper dive into its financial performance and strategic investments, interested parties can Explore financial highlights. SomaLogic continues to be a pioneer in protein biomarker discovery and commercial-stage proteomics.